StockData
Edgewise Therapeutics, Inc. logo

Edgewise Therapeutics, Inc. (EWTX) stock

EWTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 7/30
$41.37−0.67 (-1.59%)

Close on Nov 18, 2026Market cap $4.49BP/E –Yield –

Edgewise Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Edgewise Therapeutics's market cap was $5.13B on Nov 11, 2026, against $2.75B a year earlier. Over the last 5 years it ranged from $309.73M to $5.13B, with a median of $1.36B.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$5.13B+95.3%
2025Dec 31, 2025$2.62B+4.1%
2024Dec 31, 2024$2.52B+263.1%
2023Dec 29, 2023$694.26M+22.9%
2022Dec 30, 2022$565.09M-25.0%
2021Dec 31, 2021$753.24M–

More Edgewise Therapeutics figures

See a number that looks wrong?